High frequency of HPV genotypes 59, 66, 52, 51, 39 and 56 in women from Western Mexico.
Andrea Molina-PinedaMaría Guadalupe López-CardonaLaura Patricia Limón-ToledoJuan Carlos Cantón-RomeroMaría Guadalupe Martínez-SilvaHolanda Vanesa Ramos-SánchezMaría Guadalupe Flores-MiramontesPedro de la Mata-GonzálezLuis F Jave-SuárezAdriana Del Carmen Aguilar-LemarroyPublished in: BMC infectious diseases (2020)
Our data indicate that there is a high prevalence of HPV genotypes which are not covered by the vaccines currently available in Mexico; therefore, it is necessary to include HPVs 59, 66, 51, 39 and 56 in the design of future vaccines to reduce the risk of CC development. It is also essential to emphasize that the use of hormonal contraceptives and tobacco smoking are risk factors for CC development in addition to the presence of HPV.